J Wahren1, B L Johansson, H Wallberg-Henriksson
1Department of Clinical Physiology, Karolinska Hospital, Stockholm, Sweden.
C-peptide administration in insulin-dependent diabetes (IDDM) patients improved kidney function, metabolic control, and autonomic neuropathy. These findings suggest C-peptide has significant physiological effects beyond insulin.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: